Berliner Tageszeitung - US actor Kevin Spacey denies seven new sex offences

NYSE - LSE

RBGPF	0%	60.72	$
CMSC	0.5%	22.443	$
BCE	-0.34%	24.195	$
BCC	1.79%	72.435	$
RIO	0.83%	106.23	$
RYCEF	2.63%	17.5	$
GSK	-0.98%	52.525	$
NGG	-0.15%	81.72	$
RELX	-2.34%	32.97	$
JRI	0.85%	12.775	$
CMSD	0.58%	22.39	$
VOD	-2.81%	15.105	$
BP	-2.53%	41.725	$
AZN	-0.78%	177.36	$
BTI	-1.76%	61.24	$

US actor Kevin Spacey denies seven new sex offences

BOULEVARD 13.01.2023

Oscar-winning Hollywood actor Kevin Spacey on Friday denied charges of committing seven new sexual offences against a man in Britain in the early 2000s.

Text size:

The 63-year-old star of Oscar-winning film "American Beauty" and drama series "House of Cards" appeared at Southwark Crown Court in south London via videolink.

He spoke to confirm his identity and plead not guilty to the charges.

Spacey's stellar career has been halted by large numbers of allegations of sexual offences although he has not been convicted of any crime.

The actor was slapped with the fresh charges involving one man in November, taking the total number of charges he faces in the UK to 12.

Last summer he appeared at London's Old Bailey court to plead not guilty to five charges of similar sexual offences against three other men.

Now on unconditional bail, Spacey will face a four-week trial in London, starting June 6, which will consider all the charges.

The new charges are three counts of indecent assault, three counts of sexual assault and one count of causing a person to engage in sexual activity without consent, allegedly committed between 2001 and 2005.

None of the alleged victims can be identified under English law and reporting restrictions prevent further details being disclosed before trial.

Spacey enjoyed a highly successful acting career with roles such as a middle-aged father lusting after a teen in "American Beauty," a serial killer in "Se7en" and the villain in "Superman Returns".

He worked as artistic director at London's Old Vic Theatre between 2004 and 2015.

This success all came crashing down in 2017 when he was one of the first stars caught up in the global #MeToo movement and was accused of sexual assault by multiple young men.

He was dropped from the final season of the political drama "House of Cards" and other projects.

Last year a New York court dismissed a $40 million sexual misconduct lawsuit brought against Spacey.

The complainant, actor Anthony Rapp, alleged the star had assaulted him when he was 14. He brought the civil case after being told it was too late to bring a criminal charge.

In 2019, charges of indecent and sexual assault were dropped against Spacey in Massachusetts.

In court appearances, Spacey has denied all allegations of sexual assault.

H. Müller--BTZ

Featured

'They want to destroy us': Shock and anger as Russian attack sets Kyiv cathedral ablaze

Father Makariy, a high-ranking clergyman at Kyiv's Pechersk Lavra monastery complex, was woken at around 5:00 am with a huge roar -- the cathedral at the heart of one of Orthodox Christianity's most important sites had been set on fire in a Russian attack.

Burnt-out Indonesians beat the blues with children's games

Flushed and sweating, 31-year-old Annisa Enggracia Fidel runs back and forth to defend her fort from invaders -- hundreds of fellow adults all beating the blues by playing a nostalgic Indonesian children's game.

Greek fishermen struggle to keep up with pufferfish invaders

On his fishing boat moored in the Greek port of Ierapetra in southwestern Crete, Alexis Charlambakis pries open the mouth of a freshly-caught pufferfish to reveal two massive teeth on each jaw.

BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF

VANCOUVER, BC / ACCESS Newswire / June 15, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it has commenced work with a Business Development & Licensing ("BD&L") specialist advisor to support the commercialization and partnering strategy for BNT23001, the Company's patented proprietary sublingual Cladribine orally dissolvable film ("ODF") formulation for the treatment of multiple sclerosis ("MS").